We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Dyadic Welcomes New Chief Operating Officer
News

Dyadic Welcomes New Chief Operating Officer

Dyadic Welcomes New Chief Operating Officer
News

Dyadic Welcomes New Chief Operating Officer

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Dyadic Welcomes New Chief Operating Officer"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Dyadic International, Inc. has announced that Danai Brooks will join the Company as Executive Vice President and Chief Operating Officer in June.

Brooks joins Dyadic from J.P. Morgan where he served as a Vice President in the firm’s Investment Bank.

“Danai has significant financial and operational experience in the renewable energy and bio-based chemical space, and will be a tremendous asset to Dyadic,” said Mark Emalfarb, Dyadic’s President and Chief Executive Officer.

Emalfarb continued, “As EVP and COO, Danai will play a key role in driving our business development and licensing efforts, as well as corporate strategic planning and operational improvements across the globe.”

“As a long-time advisor to Dyadic, I am intimately familiar with the Company and thrilled to have the opportunity to join the team” said Brooks.

Brooks continued, “Dyadic continues to compete with larger industrial enzyme companies using its game-changing C1 enzyme expression platform. Together, we will continue to build commercial momentum through enzyme sales and strategic partnerships across a wide range of sectors including cellulosic biofuels, biopharmaceuticals and industrial applications. We look forward to introducing new C1-based products to the many industries and companies that can benefit from C1’s ability to produce enzymes and other proteins with class leading performance.”

While at J.P. Morgan, Brooks advised clients across a broad spectrum of sectors, including chemicals, renewable energy and industrials.

He has held senior operational, engineering and manufacturing positions with Dell Inc., Mars Inc. and Ford Motor Company.

He received a B.S. in Industrial Engineering and Master of Engineering from Cornell University, a Master of Engineering Management from Northwestern University and an MBA from Northwestern’s Kellogg School of Management.

Advertisement